Circulating endothelial cells and rheumatoid arthritis: Relationship with plasma markers of endothelial damage/dysfunction

Rheumatology

Volumn 48, Issue 3, 2009, Pages 285-288

  Foster, Will ^a   Shantsila, Eduard ^a   Carruthers, David ^a   Lip, Gregory Y H ^a   Blann, Andrew D ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

C reactive protein; Circulating endothelial cells; Rheumatoid arthritis; Soluble E selectin; von Willebrand factor

Indexed keywords

C REACTIVE PROTEIN; CD146 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CELL COUNT; CROSS-SECTIONAL STUDIES; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED;

EID: 61349118173     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken486     Document Type: Article

References (25)

1. del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
2. Blann AD. Viewpoint: Endothelial cell activation, injury, damage and dysfunction: Separate entities or mutual terms? Blood Coagul Fibrinolysis 2000;11:623-30.
3. Rothschild BM, Masi AT. Pathogenesis of rheumatoid arthritis: A vascular hypothesis. Arthritis Rheum 1982;12:11-31.
4. Rodlan V, Marin F, Lip GYH, Blann AD. Soluble E selectin in cardiovascular disease and its risk factors. Thromb Haemostasis 2003;90:1007-20.
5. Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost 2006;95:49-55.
6. Lee KW, Lip GY, Tayebjee M, Foster W, Blann AD. Circulating endothelial cells, von Willebrand factor, interleukin-6 and prognosis in patients with acute coronary syndromes. Blood 2005;105:526-32.
7. Blann AD, Woywodt A, Bertolini F et al. Circulating endothelial cells: Biomarker of vascular disease. Thromb Haemost 2005;93:228-35.
8. Clancy R, Marder G, Martin V, Belmont HM, Abramson SB, Buyon J. Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy. Arthritis Rheum 2001;44:1203-8.
9. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 2003;361:206-10.
10. Kerekes G, Szekanecz Z, Dér H et al. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: A multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 2008;35:398-406.
11. Wållberg-Jonsson S, Caidahl K, Klintland N, Nyberg G, Rantapää-Dahlqvist S. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis. Scand J Rheumatol 2008;37:1-5.
12. Szekanecz Z, Kerekes G, Dér H et al. Accelerated atherosclerosis in rheumatoid arthritis. Ann NY Acad Sci 2007;1108:349-58.
13. Klimiuk PA, Fiedorczyk M, Sierakowski S, Chwiecko J. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis. Scand J Rheumatol 2007;36:345-50.
14. Blann AD, Herrick A, Jayson MIV. Soluble adhesion molecules E-selectin, ICAM and VCAM in the inflammatory vasculitides: Relationship with disease severity and established laboratory indices. Br J Rheumatol 1995;34:814-19.
15. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. Emery P, Gabay C, Kraan M, Gomez-Reino J. Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis. Rheumatol Int 2007;27:793-806.
17. Blann AD, Hopkins J, Winkles J, Wainwright AC. Plasma and serum von Willebrand factor antigen levels in connective tissue disorders. Ann Clin Biochem 1992;29:67-71.
18. Woywodt A, Goldberg C, Kirsch T et al. Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis. Ann Rheum Dis 2006;65:164-8.
19. McClung JA, Naseer N, Saleem M et al. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia 2005;48:345-50.
20. Nadar SK, Lip GY, Lee KW, Blann AD. Circulating endothelial cells in acute ischaemic stroke. Thromb Haemost 2005;94:707-12.
21. Mutunga M, Fulton B, Bullock R et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001;163:195-200.
22. Blann AD, Pretorius A. Circulating endothelial cells and endothelial progenitor cells: Two sides of the same coin, or two different coins? Atherosclerosis 2006; 188:12-18.
23. Goon PK, Boos CJ, Stonelake PS, Blann AD, Lip GY. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: A methodological comparison. Thromb Haemost 2006; 96:45-52.
24. Delorme B, Basire A, Gentile C et al. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thromb Haemost 2005;94:1270-9.
25. Makin AJ, Chung NA, Silverman SH, Blann AD, Lip GYH. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells: Relationship with von Willebrand factor and tissue factor. Eur Heart J 2004;25:371-6.